Diverse Medical
AI for all.


Who We Are

Creating a world filled with medical AI

We aim to realize a future where various medical AIs seamlessly integrate into daily clinical settings, existing in forms tailored to individual diseases and patients, and collaborate with healthcare professionals to provide the best care for each patient.

  • Supporting the Generation and
    Advancement of Over 100 Medical AI Technologies

  • Building the world’s best
    medical data center

  • Developing a Sustainable Economy for Medical AI

Goal by 2030

How We Do

In Japan, despite the abundance of high-quality medical data, the utilization of AI in healthcare is still in its early stages. Our solution to this situation involves tackling challenges in data standardization, acquisition, and processing. To achieve this, we are expanding our network of medical data providers and supporting smooth data transfer. Additionally, we are focused on promoting the effective use of data, not just in data-related areas but also in the development, regulatory affairs, and commercialization of medical AI.

Current Status


Significant hurdles exist for both the providers and users of data.

  • Providers
    (medical institutions, etc.)

    ・Deficiency of Knowledge and Resources in Providing Data
    ・Difficulties in the Standardization and Consistency of Medical Data
    ・Insufficient Support for the Effective Use of Medical Data

  • Acquirer
    (e.g., medical AI developers)

    ・Challenges in Pinpointing and Obtaining the Right Data
    ・Barriers in Data Preparation (Annotation, Quality Tuning) for Development
    ・Challenges in Regulatory Submissions and Market Launch Post-development


Support for data providers and acquirers to promote data distribution and utilization.

  • Promotion of data

    ・Form partnerships with multiple scholarly societies and medical facilities to boost the pool of data providers
    ・Provide data provision expertise to suppliers and support smooth data delivery.
    ・Compensate data suppliers with usage payments and support the adoption of medical AI.

  • Promotion of data

    ・Assist in defining data required for development and in supporting data annotation
    ・Support commercialization activities such as obtaining regulatory approvals and sales
    ・Introduce superior medical AI from abroad to Japan.

Use Cases


We aim to become an authorized entity under the Next Generation Medical Infrastructure Act to further promet the distribution and utilization of data

Supporting the entire process of medical AI development for Medical Images

  • Specialized in medical images

    By leveraging our knowledge and database specialized in medical images, we drive valuable data utilization for both data providers and developers

  • Diverse Experts in the team

    With our team of experts from various fields such as medical data processing, regulatory affairs, and commercialization, we are capable of providing holistic support to clients

  • Consistent service

    We realize swift and seamless service by conducting the entire process from data gathering to delivery in-house

Flow of data provision

  1. Initial meeting

    We will discuss the contents of data provision, provision procedures, contract forms, etc., in preparation for data provision.

  2. Application for ethics review documents

    We will support your preparation of ethics review documents, etc.

  3. Conclusion of provision contract

    We conclude the necessary contracts for data provision.

  4. Extraction and processing of data

    We will support data extraction and processing upon your request.

  5. Provision of data

    Only processed data will be stored and utilized by our company.

  6. Payment of the data provision fee

    Based on the contract, we will pay the data provision fee.


  • 島原 佑基

    Yuki Shimahara Director | CEO

    Completed a doctoral program in Life Sciences at the Graduate School of Frontier Sciences, The University of Tokyo. Founded LPIXEL Inc. in 2014 and served as the CEO, focusing on AI-based image analysis in the medical and drug discovery sectors. Currently active as a founder, serving as a permanent director of the Japan Association of Medical Imaging Systems Industry, and working on the creation of data processing guidelines for the Ministry of Health, Labour and Welfare's scientific research funds project (2021-2023). Also contributes to medical AI education as a part-time lecturer at universities such as Kochi University, Hokkaido University, and Tokyo Medical and Dental University.

  • 島原 佑基

    Sho Kawabe Director

    Holds a Master of Business Administration (MBA) from the University of Michigan's Ross School of Business, and is a licensed pharmacist. Started career in the regulatory affairs department of Nihon Kohden Corporation, a medical device manufacturer, focusing on market approval registration, insurance submissions, and managing both domestic and international inspections. Subsequently engaged in roles including project management, international business development, and regulatory and quality affairs at several medical AI startups, notably at LPIXEL Inc

  • 島原 佑基

    Hiroaki Hyakutake Director

    Graduated from the Department of Biochemical Engineering, Faculty of Engineering, Gunma University. Worked in regulatory affairs in both domestic and multinational medical device manufacturers and medical device import trading companies, dealing with device approval/certification applications, clinical trials, and insurance submissions. At LPIXEL Inc., responsible for regulatory submissions for programmed medical devices and obtaining and maintaining ISO 13485 certification, and continues to support regulatory affairs for numerous medical devices.

  • Daiju Ueda Director

    Special Associate Professor at the Health Science Innovation Center, Osaka Public University. As a clinician, specializes in image diagnosis, and as a research physician, in Artificial Intelligence. Works as the academic counterpart in medical AI projects with various domestic and international companies.

  • Takeshi Ide Director

    Graduated from the Faculty of Medicine, Osaka University (Doctor of Medicine) and completed a doctoral program at the Graduate School of Medicine, Osaka University (Ph.D. in Medicine). Studied abroad at Bascom Palmer Eye Institute, University of Miami, USA. After serving as the Vice Director at Minami-Aoyama Eye Clinic, graduated from the Graduate School of Business and Finance, University of Business and Distribution Sciences (Master in Business and Finance) and then established Tokyo Vision Eye Clinic Asagaya. Alongside serving as the clinic's director, also founded NYAUW Co., Ltd., engaging in activities aimed at solving clinic challenges from the perspective of a practicing physician.

  • Joe Sakai Outer Director

    Graduated from the Faculty of Science and Technology, Keio University, and obtained a Master of Business Administration (MBA) with distinction from TIAS School for Business and Society in the Netherlands. Founder and director of Rixis, former visiting professor in the Department of Life Science and Bio-Industrial Sciences at Niigata University of Pharmacy and Applied Life Sciences, board member of NPO Katariba, and advisor to the Professional Baseball Players Association.

  • Akio Kamiyama Auditor

    Graduated from the Department of Political Science, Faculty of Law, Keio University. Worked in private equity at Advantage Partners. President and CEO of Kokoromi Inc. Founded Kokoromi Inc. to launch services aimed at the elderly.

  • Koji Mizumura Corporate Officer

    Graduated from the Faculty of Economics, Kanagawa University. Established Switch Tax Corporation and has served as a director in various companies in the construction, IT, and beauty industries, responsible for business promotion and finance. Currently the representative partner of any Tax Corporation and a director at KEIPE Inc. Licensed tax accountant

  • Hayato Nakazawa Legal Officer

    Completed the Graduate School of Law at Hitotsubashi University. Representative lawyer at ant Law Office (member of the Second Tokyo Bar Association). After supporting legal affairs for startups at GVA Law Office, worked on AI product development and PMM at GVA TECH Inc. Currently provides legal advice mainly in startup law, AI, and data law.

  • Yasumasa Takaki Design Officer

    Worked in production companies and as a freelancer, then served as Chief Design Officer at LIVESENSE Inc., LPIXEL Inc., and MOTA Inc., leading brand strategy as a director and designer.

Expert Commitee

  • Hiroshi Fujita Expert (Medical AI)

    Completed graduate studies at Gifu University. Doctor of Engineering (Nagoya University). Served as a visiting researcher at the University of Chicago and professor in the Faculty of Engineering and Medicine at Gifu University. Currently a special professor/emeritus professor at Gifu University and visiting professor at Fujita Health University and Shiga University of Medical Science. Long engaged in research and development of Computer-Aided Diagnosis (CAD) in medicine. Honorary chairman of the Society for Medical Image Information and a fellow of the Institute of Electronics, Information and Communication Engineers.

  • Yasuyuki Kobayashi Expert (Medical AI)

    Graduated from Asahikawa Medical University, School of Medicine. Radiology specialist. Deputy Director of the Digital Health Co-Creation Center and professor in the Graduate School of Medical Information Technology Application at St. Marianna University School of Medicine. Leads the 'Healthcare Professionals 2030' training project, focusing on research and education in medical AI.

  • Sese Jun Expert (R&D)

    Ph.D. in Science from the Graduate School of Frontier Sciences at the University of Tokyo. President and CEO of Humanome Research Institute. Former assistant professor at the University of Tokyo, associate professor at Ochanomizu University and Tokyo Institute of Technology, and research team leader at the National Institute of Advanced Industrial Science and Technology. Specializes in machine learning, mathematical statistics, and large-scale data analysis in life sciences.

  • Makoto Uchida Expert (Legal)

    Graduated from the Faculty of Engineering, Kyoto University, majoring in Physical Engineering. Lawyer and patent attorney. After working at Okada Haruo General Law Office, established iCraft Law Office. Member of the Ministry of Economy, Trade and Industry's 'AI and Data Contract Guidelines Study Group' and 'AMED Research Data Handling Study Group'. Specializes in intellectual property strategy for startups, intellectual property disputes, system development disputes, personal information protection law, data transactions, and legal affairs related to AI.

  • Norio Sawa Expert (Security)

    Graduated from the Faculty of Engineering, Tokai University, majoring in Electronic Engineering. Worked for 20 years at Nippon Electronic Calculation Co., Ltd. as the head of data centers for finance, securities, local governments, and general companies. Obtained multiple ISO certifications, including FISC compliance and ISMS. Currently runs an IT consulting firm, providing information security and IT consulting for numerous companies.


  • Kiyoshi Kurokawa Advisor

    Graduated from the Faculty of Medicine, University of Tokyo. Served as a professor of internal medicine at UCLA Medical School, the University of Tokyo, and as the Dean of the School of Medicine at Tokai University. Member of the Council for Science and Technology (2003-2006), special advisor to the Cabinet (2006-2008), and health and medical strategy advisor in the Cabinet Secretariat (2013-2019). Currently a committee member and vice-chairman of the World Dementia Council, honorary professor at the National Graduate Institute for Policy Studies and the University of Tokyo. Special honorary professor at Tokai University





  1. 情報資産の機密性、完全性、可用性を確実に保護するために組織的、技術的に適切な対策を講じ、変化する情報技術や新たな脅威に対応する。
  2. 全業務担当者に情報セキュリティ教育の実施と方針の周知徹底をはかり、意識の高揚・維持に務める。
  3. マネジメントシステム及び、情報セキュリティに関する目的を設定し、定期的にレビューし、継続的に改善を実施し、維持する。
  4. マネジメントシステムを実行・維持・改善して行くために管理責任者に責任と権限を委譲する。

代表取締役 島原 佑基